LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.17783
 49.63 27.76 89 4818 0.0185 0.1695
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 49.63 27.76 2388 4818 0.4956 0.8199
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 51.33 27.76 60 5117 0.0117 0.1078
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 51.33 27.76 2193 5117 0.4286 0.7871
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 51.33 27.76 76 5117 0.0149 0.1432
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 51.33 27.76 2504 5117 0.4893 0.8188
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 53.04 27.76 63 5365 0.0117 0.1140
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 53.04 27.76 2323 5365 0.4329 0.7913
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 53.04 27.76 89 5365 0.0166 0.1658
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 53.04 27.76 2639 5365 0.4918 0.8216
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 54.74 27.76 91 5606 0.0162 0.1677
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 54.74 27.76 2421 5606 0.4318 0.7923
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 54.74 27.76 103 5606 0.0184 0.1868
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 54.74 27.76 2777 5606 0.4953 0.8247
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 56.45 27.76 79 5745 0.0138 0.1456
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 56.45 27.76 2523 5745 0.4391 0.7971
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 56.45 27.76 111 5745 0.0193 0.1974
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 56.45 27.76 2942 5745 0.5121 0.8334
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 58.15 27.76 88 5906 0.0149 0.1609
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 58.15 27.76 2638 5906 0.4466 0.8020
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 58.15 27.76 125 5906 0.0212 0.2148
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 58.15 27.76 3111 5906 0.5267 0.8409
MN20160318_Q01
G15
MCF 10A-H2B-mCherry Dasatinib
0.17783
 59.85 27.76 97 6062 0.0160 0.1747
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 59.85 27.76 2807 6062 0.4630 0.8113
MN20160318_Q01
E22
MCF 10A-H2B-mCherry Dasatinib
0.17783
 59.85 27.76 163 6062 0.0269 0.2558
MN20160318_Q01
G15